1. Andrade, H., Shinotsuka, C., da Silva, I., Donini, C., Yeh, L., de Carvalho, F., Bozza, A & Miguel, A. (2017). Highly active antiretroviral therapy for critically ill HIV patients: A systematic review and meta-analysis. PLOS One, 12(10), 1-12, http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0186968&type=printable
2. Ayalew, B. (2017). Mortality and its predictors among HIV-infected patients taking antiretroviral treatment in Ethiopia: A systematic review. AIDS Research and Treatment, 2017, 1-10, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682904/pdf/ART2017-5415298.pdf
3. Betancur, N., Brites, C., Lins, L & Oliveira, R. (2017). Quality of life, anxiety and depression in patients with HIV/AIDS who present poor adherence to antiretroviral therapy: A cross-sectional study in Salvador, Brazil. Brazilian Journal of Infectious Diseases, 21(5), 507-514, http://www.scielo.br/pdf/bjid/v21n5/1413-8670-bjid-21-05-0507.pdf
4. Brites, C., Netto, M & Nobrega, I. (2017). Use of new antiretroviral drugs and classes in Bahia, Brazil: A real life experience on salvage therapy of AIDS patients. Brazilian Journal of Infectious Diseases, 19(5), 529-532, https://ac.els-cdn.com/S1413867015000859/1-s2.0-S1413867015000859-main.pdf?_tid=8c6e4c1a-808d-4e54-8172-72e52f430462&acdnat=1527253355_1feeda4fc999b1bd4cfff9b6669c495f
5. Brown, A., Burns, F., Copas, A., Croxford, S., Delpech, V., Desai, S.,Edelstein, M., Kall, M., Kitching, A., Skingsley, A & Sullivan, A. (2017). Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: An analysis of a national observational cohort. The Lancet, 2(1), 35-46, https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(16)30020-2/fulltext
6. Buonomo, E., Ciccacci, F., Gennaro, E., Germano, P., Guidotti, G., Jere, H., Liotta, G., Magid, A., Mancinelli, S., Marazzi, C., Palombi, L., Saines, N & Scarcella, P. (2013). Reduction of maternal mortality with highly active antiretroviral therapy in a large cohort of HIV-infected pregnant women in Malawi and Mozambique. PLOS One, 8(8), 1-7, http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0071653&type=printable
7. Kakaire, O., Kakande, N., Kaye, K., Lule, C & Osinde, O. (2013). The impact of highly active antiretroviral therapy on high-risk behavior of HIV-infected patients in Sub-Saharan Africa. Journal of Infection in Developing Countries, 7(6), 436-447, https://pdfs.semanticscholar.org/e2d0/b6827751e03929013045b73bb6a6589a9650.pdf
8. Li, G., Li, S., Qin, X., Riying, L., Wu, J & Zhu, Y. (2016). Research on AIDS patients’ survival time after highly active antiretroviral therapy, treatment effect and treatment modes. Saudi Pharmaceutical Journal, 24(3), 318-321, https://www.sciencedirect.com/science/article/pii/S1319016416300056
9. Ramana, K. (2014). Effect of highly active antiretroviral therapy (HAART) on human immunodeficiency virus disease pathogenesis and progression. American Journal of Public Health Research, 2(3), 68-74, https://pdfs.semanticscholar.org/9d92/1ba926cdc9d39addf57969dead10a687df66.pdf
The download will start shortly.